Purification and characterization of a stimulator of plasmin generation from the antiangiogenic agent Neovastat: Identification as immunoglobulin kappa light chain

Archives of Biochemistry and Biophysics

Volumn 431, Issue 2, 2004, Pages 197-206

  Boivin, Dominique ^a   Provençal, Mathieu ^a   Gendron, Sébastien ^a   Ratel, David ^a   Demeule, Michel ^a   Gingras, Denis ^a   Béliveau, Richard ^a  

^a UNIVERSITY OF MONTREAL   (Canada)

Author keywords

AE 941; Angiogenesis; Endothelial cells; Immunoglobulin; Neovastat; Plasminogen activator; Shark cartilage

Indexed keywords

AE 941; ANGIOGENESIS INHIBITOR; IMMUNOGLOBULIN KAPPA CHAIN; PLASMINOGEN; PLASMINOGEN ACTIVATOR;

AMINO TERMINAL SEQUENCE; ANTIANGIOGENIC ACTIVITY; ARTICLE; BINDING KINETICS; DRUG IDENTIFICATION; DRUG PROTEIN BINDING; DRUG PURIFICATION; GEL FILTRATION; IN VITRO STUDY; ISOELECTRIC FOCUSING; PLASMINOGEN ACTIVATION; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN DEGRADATION; SEQUENCE ANALYSIS; SURFACE PLASMON RESONANCE;

AMINO ACID SEQUENCE; ANGIOGENESIS INHIBITORS; CHROMATOGRAPHY, GEL; ELECTROPHORESIS, POLYACRYLAMIDE GEL; FIBRIN; IMMUNOGLOBULIN KAPPA-CHAINS; ISOELECTRIC FOCUSING; ISOELECTRIC POINT; KINETICS; MOLECULAR SEQUENCE DATA; MOLECULAR WEIGHT; PLASMIN; PLASMINOGEN; SEQUENCE ANALYSIS, PROTEIN; SURFACE PLASMON RESONANCE; TISSUE EXTRACTS;

CHONDRICHTHYES;

EID: 5644264939     PISSN: 00039861     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.abb.2004.08.022     Document Type: Article

References (40)

1. J. Folkman Nat. Med. 1 1995 27 31
2. D. Hanahan, and J. Folkman Cell 86 1996 353 364
3. M.S. Pepper Arterioscler. Thromb. Vasc. Biol. 21 2001 1104 1117
4. H.R. Lijnen, and D. Collen Baillière's Clin. Haematol. 8 1995 277 290
5. G. Murphy, and J. Gavrilovic Curr. Opin. Cell Biol. 11 1999 614 621
6. M.R. Gyetko, R.F. Todd III, C.C. Wilkerson, and R.G. Sitrin J. Clin. Invest. 93 1994 1380 1398
7. H.Y. Min, L.V. Doyle, C.R. Vitt, L. Zandonella, J.R. Stratton-Thomas, M.A. Shuman, and S. Rosenberg Cancer Res. 56 1996 2428 2433
8. D. Huber, E.M. Cramer, J.E. Kaufmann, P. Meda, J.-M. Massé, E.K.O. Kruithof, and U.M. Vischer Blood 99 2002 3637 3645
9. D. Gingras, D. Labelle, C. Nyalendo, D. Boivin, M. Demeule, C. Barthomeuf, and R. Béliveau Invest. New Drugs 22 2004 17 26
10. M.A. Lafleur, M.M. Handsley, V. Knäuper, G. Murphy, and D.R. Edwards J. Cell Sci. 115 2002 3427 3438
11. M.S. O'Reilly, L. Holmgren, Y. Shing, C. Chen, R.A. Rosenthal, M. Moses, W.S. Lane, Y. Cao, E.H. Sage, and J. Folkman Cell 79 1994 315 328
12. C.M. Ferrier, S. Suciu, W.L. van Geloof, H. Straatman, A.M.M. Eggermont, H.S. Koops, B.B.R. Kroon, F.J. Lejeune, U.R. Kleeberg, G.N.P. van Muijen, and D.J. Ruiter Br. J. Cancer 83 2000 1351 1359
13. P.O. Chappuis, B. Dieterich, V. Sciretta, C. Lohse, H. Bonnefoi, S. Remadi, and A.-P. Sappino J. Clin. Oncol. 2001 2731 2738
14. R. Sawaya, O.J. Ramo, M.L. Shi, and G. Mandybur J. Neurosurg. 74 1991 480 486
15. A. Reijerkerk, E.E. Voest, and M.F.B.G. Gebbink Eur. J. Cancer 36 2000 1695 1705
16. D. Gingras, G. Batist, and R. Béliveau Expert Rev. Anticancer Ther. 1 2001 341 347
17. G. Batist, F. Patenaude, P. Champagne, D. Croteau, C. Levinton, C. Hariton, B. Escudier, and E. Dupont Ann. Oncol. 13 2002 1259 1263
18. P. Falardeau, P. Champagne, P. Poyet, C. Hariton, and E. Dupont Semin. Oncol. 28 2001 620 625
19. D. Gingras, A. Renaud, N. Mousseau, E. Beaulieu, Z. Kachra, and R. Béliveau Anticancer Res. 21 2001 145 155
20. R. Béliveau, D. Gingras, E.A. Kruger, S. Lamy, P. Sirois, B. Simard, M.G. Sirois, L. Tranqui, F. Baffert, E. Beaulieu, V. Dimitriadou, M.-C. Pépin, F. Courjal, I. Ricard, P. Poyet, P. Falardeau, W.D. Figg, and E. Dupont Clin. Cancer. Res. 8 2002 1242 1250
21. D. Boivin, S. Gendron, E. Beaulieu, D. Gingras, and R. Béliveau Mol. Cancer Ther. 1 2002 795 802
22. E. Dupont, P. Falardeau, S.A. Mousa, V. Dimitriadou, M.-C. Pépin, T. Wang, and M.A. Alaoui-Jamali Clin. Exp. Metastasis 19 2002 145 153
23. E. Dupont, P. Brazeau, C. Juneau, United States Patent, 5,618,925. Government Printing Office, Washington, DC, 1997
24. J.C. Drapier, J.P. Tenu, G. Lemaire, and J.F. Petit Biochimie 61 1979 463 471
25. M. Ranby Biochim. Biophys. Acta 704 1982 461 469
26. A.S. Greenberg, L. Steiner, M. Kasahara, and M.F. Flajnik Proc. Natl. Acad. Sci. USA 90 1993 10603 10607
27. R. Eisenstein, N. Sorgente, L.W. Soble, A. Miller, and K.E. Kuettner Am. J. Pathol. 73 1973 765 774
28. N. Sorgente, K.E. Kuettner, L.W. Soble, and R. Eisenstein Lab. Invest. 32 1975 217 222
29. J.R. Sheu, C.C. Fu, M.L. Tsai, and W.J. Chung Anticancer Res. 18 6A 1998 4435 4441
30. X.R. Shen, D.M. Ji, F.X. Jia, X.X. Deng, J.H. Sun, X.R. Hu, and D.M. Ren Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai) 32 2000 43 48
31. J.H. Liang, and K.P. Wong M. Maragouchakis Angiogenesis: From the Molecular to Integrative Pharmacology 2000 Klewer Academic/Plenium publishers New York 209 223
32. A. Sellers, G. Murphy, M.C. Meikle, and J.J. Reynolds Biochem. Biophys. Res. Commun. 87 1979 581 587
33. M. Zafarullah, S. Su, J. Martel-Pelletier, J.A. DiBattista, B.G. Costello, W.G. Stetler-Stevenson, and J.P. Pelletier J. Cell. Biochem. 60 1996 211 217
34. S.S. Apte, K. Hayashi, M.F. Seldin, M.G. Mattei, M. Hayashi, and B.R. Olsen Dev. Dyn. 200 1994 177 197
35. M.A. Moses, J. Sudhalter, and R. Langer Science 248 1990 1408 1410
36. J.B. Murray, K. Allison, J. Sudhalter, and R. Langer J. Biol. Chem. 261 1986 4154 4159
37. Y. Hiraki, H. Inoue, K. Iyama, A. Kamizono, M. Ochiai, C. Shukunami, S. Iijima, F. Suzuki, and J. Kondo J. Biol. Chem. 272 1997 32419 32426
38. D.J. Good, P.J. Polverini, F. Rastinejad, M.M. Le Beau, R.S. Lemons, W.A. Frazier, and N.P. Bouck Proc. Natl. Acad. Sci. USA 87 1990 6624 6628
39. M.A. Moses, D. Wiederschain, I. Wu, C.A. Fernandez, V. Ghazizadeh, W.S. Lane, E. Flynn, A. Sytkowski, T. Tao, and R. Langer Proc. Natl. Acad. Sci. USA 96 1999 2645 2650
40. P.C. Harpel, R. Sullivan, and T.S. Chang J. Biol. Chem. 264 1989 616 624